CClinicalTrials.gg
CompletedNCT07797010L2TUpdated Sep 1, 2026

Learning to THRIVE (L2T) Program Pilot

An interventional study of Learning to THRIVE (L2T) Program in Interstitial Cystitis and Bladder Pain Syndrome, sponsored by University of Indianapolis. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by University of Indianapolis · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This pilot study evaluated the feasibility and potential effects of Learning to THRIVE (L2T), a six-week online educational self-management program for adults who self-identified as women or female and had interstitial cystitis/bladder pain syndrome (IC/BPS). L2T combined self-paced online educational materials with a weekly live virtual group session. The primary feasibility objectives were recruitment, engagement, and retention. Exploratory outcomes included IC/BPS symptom and problem severity, pain intensity, pain-related interference and distress, and self-efficacy for chronic disease management. Qualitative data were collected to understand participants' experiences with the program.

Read the detailed description

L2T used a flipped-classroom format over six weeks. Participants reviewed asynchronous e-learning materials each week and then attended a 60-90 minute live virtual group session facilitated by the research team to discuss and apply the lesson content. The program was informed by the THRIVE model, chronic pain science, adult learning, and instructional design principles. Quantitative assessments were conducted at baseline, immediately after the intervention, and 6 weeks after the intervention. Qualitative data were collected through open-ended survey questions, weekly lesson feedback, recordings of synchronous sessions, and post-intervention semi-structured interviews. This ClinicalTrials.gov record was entered retrospectively after study completion and was reconstructed from contemporaneous IRB-approved study materials.

02

Conditions studied

  • Interstitial Cystitis and Bladder Pain Syndrome

Keywords

  • online behavioral intervention
  • chronic pelvic pain; chronic primary pain; self-management; pain education; peer support
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Self-identifies as a woman or female
  • Age 18 years or older
  • Self-reported healthcare provider-confirmed diagnosis of interstitial cystitis/bladder pain syndrome (IC/BPS)
  • Pelvic pain, pressure, or discomfort for at least 6 months, of at least moderate severity (greater than 3 on a 0-10 numerical rating scale), causing weekly life interference and limiting life or work-related activities, general activity level, and/or enjoyment of life during the prior 3 months
  • Reliable access to a computer and Internet connection

Exclusion criteria

Exclusion Criteria:

  • Unable to speak/read English
  • Neurological condition (for example, multiple sclerosis, Parkinson disease, paraplegia) or other condition affecting the bladder
  • History or presence of cystitis caused by tuberculosis, radiation, or chemotherapy
  • Diagnosed and treated for a pelvic-related malignancy (colon, bladder, ovarian, endometrial, uterine, cervical, vaginal, or rectal cancer)
  • Physical or psychological comorbidity that would adversely affect ability to participate
  • Currently pregnant
  • Gross cognitive impairment, deafness, blindness, or severe vision/hearing problems that could not be accommodated
  • Current psychotherapy directed specifically toward relief of urological symptoms
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Learning to THRIVE Program

    Participants received the six-week Learning to THRIVE online educational self-management program.

    Behavioral: Learning to THRIVE (L2T) Program

Interventions

  • BehavioralLearning to THRIVE (L2T) Program

    A six-week online self-management program using a flipped-classroom format. Each week, participants reviewed asynchronous e-learning materials and attended one 60-90 minute live virtual group meeting facilitated by the research team. Content addressed goal setting and safe-group expectations; chronic pain and factors influencing pain; self-care, habits, and self-efficacy; relationships, communication, and sexual health; informed healthcare decision-making and evaluation of health claims; and reflection with long-term action planning.

    Also known as: Learning to THRIVE, L2T

05

What researchers measure

Primary outcomes

  1. Number of Participants Enrolled During the Recruitment Period

    Number of participants who provided informed consent and enrolled during the planned recruitment period. The protocol planned to recruit 16 participants.

    Time frame: During the recruitment period, approximately 3 weeks

  2. Participant-Reported Time Spent Reviewing Weekly Asynchronous Lessons

    Approximate time spent reviewing each weekly lesson, self-reported on the weekly lesson feedback form. Summarize using the metric used in the analysis (for example, median hours per week).

    Time frame: Weekly during the 6-week intervention

  3. Number of Weekly Live Virtual Sessions Attended

    Facilitator-recorded attendance across the six weekly synchronous virtual meetings. Each participant could attend 0 to 6 sessions; a percentage of sessions attended may also be derived.

    Time frame: During the 6-week intervention

  4. Number of Enrolled Participants Retained Through the Final Follow-Up Assessment

    Number and percentage of enrolled participants who remained in the study through the six-week post-intervention data-collection point. The protocol planned to recruit 16 participants and hoped to retain at least 12 through the intervention and post-intervention data-collection period.

    Time frame: From enrollment through 6 weeks after the 6-week intervention, approximately 12 weeks

Secondary outcomes

  1. Interstitial Cystitis Symptom Index (ICSI) Score

    O'Leary-Sant ICSI total score, range 0-20; higher scores indicate greater urinary/pain symptom severity.

    Time frame: Baseline, immediately after the 6-week intervention, and 6 weeks post-intervention

  2. Interstitial Cystitis Problem Index (ICPI) Score

    O'Leary-Sant ICPI total score, range 0-16; higher scores indicate greater symptom-related problems.

    Time frame: Baseline, immediately after the 6-week intervention, and 6 weeks post-intervention

  3. Pain Intensity Severity Category

    Pain intensity during the prior week assessed on an 11-point numerical rating scale from 0 to 10 and categorized according to the protocol as none (0), mild (1-3), moderate (4-6), or severe (7-10).

    Time frame: Baseline, immediately after the 6-week intervention, and 6 weeks post-intervention

  4. Pain Interference Severity Category

    Pain-related interference with activities during the prior week assessed on an 11-point numerical rating scale from 0 to 10 and categorized as none (0), mild (1-3), moderate (4-6), or severe (7-10).

    Time frame: Baseline, immediately after the 6-week intervention, and 6 weeks post-intervention

  5. Pain-Related Distress Severity Category

    Pain-related distress during the prior week assessed on an 11-point numerical rating scale from 0 to 10 and categorized as none (0), mild (1-3), moderate (4-6), or severe (7-10).

    Time frame: Baseline, immediately after the 6-week intervention, and 6 weeks post-intervention

  6. Self-Efficacy for Managing Chronic Disease (SEMCD) Score

    Six-item SEMCD scale scored from 1 to 10, with higher scores indicating greater confidence in managing chronic disease. The protocol included SEMCD as a quantitative outcome at all three assessments.

    Time frame: Baseline, immediately after the 6-week intervention, and 6 weeks post-intervention

Other outcomes

  1. Participant Perceptions of Program Acceptability and Experience

    Qualitative data were collected through open-ended questions on the study surveys, weekly lesson feedback, recorded live group discussions, and semi-structured post-intervention interviews. Weekly feedback addressed key takeaways, useful content, areas needing greater clarity, and additional comments. Interviews explored expectations, program structure, content usefulness, facilitator/peer interaction, safety and comfort, application of learning, and whether participants would recommend the program. Data were prospectively planned for thematic analysis.

    Time frame: Weekly during the 6-week intervention and within 1 month after intervention completion; open-ended survey data also collected at baseline, immediately post-intervention, and 6 weeks post-intervention

06

Study locations

1 site
  • University of Indianapolis
    Indianapolis, Indiana 46227, United States
07

References and documents

Individual participant data

Plan to share: Undecided — The informed consent permits possible future research use or sharing of de-identified study data, but a specific individual participant data sharing plan, access mechanism, and timetable have not yet been established.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07797010
Lead sponsor
University of Indianapolis
Responsible party
Elizabeth Moore (Principal Investigator, University of Indianapolis) — Principal investigator
First posted
Sep 1, 2026
Start date
Aug 29, 2023
Primary completion
Dec 24, 2023
Completion
Dec 24, 2023
Last update
Sep 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion